Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
PeerJ 6, e6153
Side Effects, Risks, and What Doctors Watch For The side effects are identical to Ozempic because its the same drug
Under valuation model assumptions realized through 12/31/28, the stock is modeled using: Revenue growth (CAGR): 15.9% Operating Margins: 4.5% Exit P/E Multiple: 24.7x Based on these inputs, the model estimates a target price of $33, implying 17.7% total upside from the current share price of $28 and a 6.3% annualized return over the next 2.7 years
The reported half-life of Retatrutide is Approximately 6 days
Peptide legality varies by jurisdiction and specific compound
Nausea, the most common effect, improves significantly in 30% of patients by day 10 and 70% by day 21
US$ 26.46
US$ 27.89
US$ 23.40
US$ 26.74
US$ 22.28
